How Little Moderna Made Big Waves In Trial Diversity

Moderna vaccine
Moderna talked to Scrip about how it ensured diversity in its Phase III COVID-19 vaccine trial • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Diversity & Inclusion

More from ESG